Abstract
Optical coherence tomography (OCT) is continuing its rapid expansion as
a tool for fast, high-resolution imaging for clinical diagnostics. Systems
sales grew in 2009, despite the economic crisis, with compound annual growth
rate of 20% expected through 2014. The market for OCT systems is entering a
new phase as it moves beyond ophthalmology and is applied to new medical
specialties. These are among the findings in the 2nd edition of the only
report that covers this exciting market. Technology, Applications, Market 2010.
THE OCT REPORT PROVIDES detailed analyses of the dominant OCT
technologies and applications, market forecasts, and comprehensive profiles of
systems and components providers and their products. Strategies Unlimited has
a reputation for providing deep and trustworthy reporting on photonics
markets. The report adds to the Strategies Unlimited portfolio of market
reports on optical components and systems, including optical molecular
imaging, image sensors, laser applications, and LED lighting systems.
Table of Contents
EXECUTIVE SUMMARY
1. INTRODUCTION
- 1.1 Scope, Methodology, and Information Sources
- 1.2 Overview of Market Opportunity for OCT
2. OCT TECHNICAL OVERVIEW
- 2.1 Optical Coherence Tomography Defined
- 2.2 General OCT System Description
- 2.3 OCT Versus Other Imaging Techniques
- 2.4 Emerging Trends: Fourier Domain OCT
- 2.5 Intellectual Property and Patent Status
3. CRITICAL TECHNOLOGIES
- 3.1 Source Technologies
- 3.1.1 SLEDs and Broadband ASE Sources
- 3.1.2 Swept Wavelength Sources
- 3.1.3 Femtosecond Laser Sources
- 3.2 Wavelength Considerations
- 3.3 Detection
- 3.4 Application-Specific Hardware/Software
4. COMMERCIAL APPLICATIONS OF OCT
- 4.1 OCT Applications in Medicine
- 4.1.1 History of Commercial Development of OCT in Medicine
- 4.1.2 General Market Conditions for Medical Instrumentation
- 4.1.3 Capital Equipment and Recurring Revenue
- 4.2 Applications in Ophthalmology
- 4.2.1 Introduction
- 4.2.2 Eyecare Professionals - Ophthalmologists and Optometrists
- 4.2.3 OCT Applications in Ophthalmology
- 4.2.4 Retinal Applications of OCT
- 4.2.5 Anterior Segment Applications of OCT
- 4.2.6 Corneal and Flap Thickness Measurement
- 4.2.7 Phakic IOL Sizing
- 4.2.8 OCT and Other Imaging Modalities
- 4.2.9 Technology Shift for OCT in Ophthalmology - The Introduction of
Spectral Domain OCT
- 4.2.10 Is There Still a Market for the Stratus Time Domain OCT?
- 4.2.11 Near-Term Trends in Ophthalmic OCT
- 4.2.12 Survey of Ophthalmic OCT Instruments
- 4.3 OCT Applications in Cardiovascular Medicine
- 4.3.1 Introduction
- 4.3.2 Cardiovascular Applications
- 4.3.3 Challenges in Imaging Inside Blood Vessels
- 4.3.4 Fourier Domain OCT Moves into Cardiovascular Applications
- 4.3.5 OCT vs. IVUS
- 4.3.6 Market Dynamics for Cardiovascular OCT
- 4.3.7 IP and Litigation
- 4.3.8 Acquisitions
- 4.4 OCT in Dentistry
- 4.4.1 Introduction
- 4.4.2 Dental Market Potential
- 4.4.3 Product Development
- 4.4.4 Dental Market Forecast
- 4.5 OCT in Other Medical Applications
- 4.5.1 OCT in Dermatology
- 4.5.2 OCT in Glucose Measurement
- 4.5.3 OCT in Oncology
- 4.5.4 OCT in Urology
- 4.5.5 OCT in General Medical Research
- 4.6 OCT in Nonmedical Applications
5. FUTURE TRENDS IN OCT
6. GLOBAL OCT MARKET FORECAST, 2010 - 2014
- 6.1 OCT Market Forecast in Ophthalmology
- 6.1.1 Market Size, Dynamics, and Competition
- 6.1.2 Historical Ophthalmic OCT Market Share
- 6.1.3 Stratus OCT Replacement Market
- 6.1.4 Aging opulation Dynamics
- 6.1.5 The Reimbursement Conundrum
- 6.1.6 Ophthalmic OCT Unit and Revenue Forecast
- 6.1.7 Market Split, Retinal/Anterior Segment Applications
- 6.2 Total Available Market - Other Medical
- 6.2.1 Cardiovascular
- 6.2.2 Dental
- 6.2.3 Noninvasive Glucose Measurement
- 6.2.4 Other Medical Applications
- 6.3 OCT Total Market Forecast, 2009 - 2014
- 6.3.1 Global OCT Market, Unit and Revenue Forecast
- 6.3.2 Sensitivity Analysis
- 6.4 Notes on the 2010 Forecast vs. the 2008 Forecast
7. KEY PRESS RELEASES, PRODUCT ANNOUNCEMENTS, AND CLINICAL TRIAL RESULTS
- 7.1 OCT News
- 7.2 Select Company Announcements
- 7.3 Select Clinical Trial Announcements
- 7.4 Select Funding, Merger, and Acquisition Announcements
- 7.5 Select OCT Product Release/Regulatory Approval Announcements
8. SUMMARY AND CONCLUSIONS